Development and Validation Clinician and Patient Reported Photonumeric Scales to Assess Buttocks Cellulite Severity

被引:15
|
作者
Cohen, Joel L. [1 ,2 ]
Sadick, Neil S. [3 ]
Kirby, M. Todd [4 ]
McLane, Michael P. [4 ]
Lenderking, William R. [5 ]
Bender, Randall H. [5 ,6 ]
Chen, Jun [5 ]
Hurley, David [4 ]
Knoble, Naomi B. [5 ]
Liu, Genzhou [4 ]
Xiang, Qinfang [4 ]
Davidson, Jeffrey A. [4 ]
Goldman, Mitchel P. [7 ,8 ]
机构
[1] AboutSkin Dermatol & DermSurg PC, 5340 South Quebec St,Suite 300, Greenwood Village, CO 80111 USA
[2] Univ Calif Irvine, Dermatol, Irvine, CA USA
[3] Cornell Univ, Dept Dermatol, Weill Cornell Med Coll, New York, NY 10021 USA
[4] Endo Pharmaceut Inc, Malvern, PA USA
[5] Evidera, Bethesda, MD USA
[6] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC 27515 USA
[7] Cosmet Laser Dermatol, San Diego, CA USA
[8] Univ Calif San Diego, Dermatol, San Diego, CA 92103 USA
关键词
D O I
10.1097/DSS.0000000000002756
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND The Clinician Reported Photonumeric Cellulite Severity Scale (CR-PCSS) and Patient Reported PCSS (PR-PCSS) are newly developed tools for assessing cellulite severity. OBJECTIVE To report on the reliability, validity, and ability to detect a change in cellulite severity on the buttocks of adult women with the CR-PCSS and PR-PCSS. MATERIALS AND METHODS Content validity of both scales was established through concept elicitation and cognitive interviews. Test-retest reliability was evaluated, and intra-rater (both scales) and inter-rater (CR-PCSS only) reliability were estimated using intraclass correlation coefficients (ICCs) for agreement and consistency. Ability to detect a change was determined using the Subject-Global Aesthetic Improvement Scale (GAIS) or Investigator-GAIS as anchors. RESULTS For the CR-PCSS (n = 6) at baseline and Day 2, the mean interrater ICCs were $0.70 and mean intrarater ICCs (95% confidence interval [CI]) were $0.81 (0.72-0.90) for both buttocks. For the PR-PCSS (n = 99) at baseline and Day 14, the mean test-retest reliability ICCs (95% CI) were $0.86 (0.79-0.91) for both buttocks. A clinically meaningful change was 1.0 point on the PR-PCSS and 1.0 on the CR-PCSS. CONCLUSION The CR-PCSS and PR-PCSS reliably assess cellulite severity of the buttocks and can detect a clinically meaningful change after treatment for cellulite.
引用
收藏
页码:1628 / 1635
页数:8
相关论文
共 50 条
  • [31] DEVELOPMENT AND VALIDATION OF A MUSCULOSKELETAL PATIENT REPORTED OUTCOME MEASURE
    Hill, Jonathan C.
    Thomas, Elaine
    Hill, Susan
    Foster, Nadine E.
    Rimmer, Yvonne
    Shufflebotham, Julie
    Doyle, Carol
    Larkin, Treena
    van der Windt, Danielle
    RHEUMATOLOGY, 2014, 53 : 76 - 77
  • [32] Validation of 3-and 5-point severity scales to assess ARIA-E
    Bracoud, Luc
    Klein, Gregory
    Lyons, Marco
    Scelsi, Marzia A.
    Wojtowicz, Jakub
    Bullain, Szofia
    Purcell, Derk
    Fiebach, Jochen B.
    Barakos, Jerome
    Suhy, Joyce
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (04)
  • [33] Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency Disorder
    Saldaris, Jacinta
    Weisenberg, Judith
    Pestana-Knight, Elia
    Marsh, Eric D.
    Suter, Bernhard
    Rajaraman, Rajsekar
    Heidary, Gena
    Olson, Heather E.
    Devinsky, Orrin
    Price, Dana
    Jacoby, Peter
    Leonard, Helen
    Benke, Tim A.
    Demarest, Scott
    Downs, Jenny
    JOURNAL OF CHILD NEUROLOGY, 2021, 36 (11) : 998 - 1006
  • [34] Development and validation of diagrammatic scale to assess target spot severity in cotton
    L. H. Fantin
    K. Braga
    M. G. Canteri
    A. R. Dias
    E. P. Borges
    Australasian Plant Pathology, 2018, 47 : 491 - 497
  • [35] Development and validation of diagrammatic scale to assess target spot severity in cotton
    Fantin, L. H.
    Braga, K.
    Canteri, M. G.
    Dias, A. R.
    Borges, E. P.
    AUSTRALASIAN PLANT PATHOLOGY, 2018, 47 (05) : 491 - 497
  • [36] Development & validation of scales to assess stigma related to COVID-19 in India
    Nair, Saritha
    Joshi, Aparna
    Aggarwal, Sumit
    Adhikari, Tulsi
    Mahajan, Nupur
    Diwan, Vishal
    Stephen, A.
    Devi, K. Rekha
    Mishra, Bijaya Kumar
    Yadav, Girijesh Kumar
    Kohli, Rewa
    Sahu, Damodar
    Gulati, Bal Kishan
    Sharma, Saurabh
    Yadav, Jeetendra
    Ovung, Senthanro
    Duggal, Chetna
    Sharma, Moina
    Bangar, Sampada Dipak
    Andhalkar, Rushikesh
    Rebecca, Pricilla B.
    Rani, S.
    Selvaraj, Pradeep
    Xavier, Gladston G.
    Peter, Vanessa
    Watson, Basilea
    Kannan, T.
    Asmathulla, K. S. M. D.
    Bhattacharya, Debdutta
    Turuk, Jyotirmayee
    Palo, Subrata Kumar
    Kanungo, Srikanta
    Behera, Ajit Kumar
    Pandey, Ashok Kumar
    Zaman, Kamran
    Misra, Brij Ranjan
    Kumar, Niraj
    Behera, Sthita Pragnya
    Singh, Rajeev
    Sarkar, Abu Hasan
    Narain, Kanwar
    Kant, Rajni
    Sahay, Seema
    Tiwari, Rajnarayan Ramshankar
    Thomas, Beena Elizabeth
    Panda, Samiran
    Rao, M. Vishnu Vardhana
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (01) : 156 - 164
  • [37] The development and initial validation of scales to assess attitudes toward multiple role planning
    Weitzman, LM
    Fitzgerald, LF
    JOURNAL OF CAREER ASSESSMENT, 1996, 4 (03) : 269 - 284
  • [38] Development and Validation of Scales to Assess adherence of Transdiagnostic Group Settings for ACT and CBT
    Samaan, Mareike
    Sauer, Elena
    Muller, Marie
    Fydrich, Thomas
    Diefenbacher, Albert
    Burian, Ronald
    Schade, Christoph
    Weck, Florian
    ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2020, 49 (01): : 63 - 71
  • [39] Validation of five patient-reported outcomes for atopic dermatitis severity in adults
    Silverberg, J. I.
    Margolis, D. J.
    Boguniewicz, M.
    Fonacier, L.
    Grayson, M. H.
    Ong, P. Y.
    Fuxench, Z. C.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (01) : 104 - 111
  • [40] Development and validation of the NCC-BC-A scale to assess patient-reported outcomes for breast cancer patients in China
    Ma, Fei
    Yan, Xiaoyan
    Guan, Xiuwen
    Liu, Tianmou
    CANCER INNOVATION, 2024, 3 (06):